CNX Therapeutics
Claire Masterson serves as the Chief Financial Officer at CNX Therapeutics since July 2024 and is also an Advisory Board Member at Gateway 21. Prior to these roles, Claire held significant positions at caresyntax, including Chief Financial Officer and Audit Committee member, during which the company provided AI-powered workflow automation and analytics for surgical teams and hospital management. Claire also contributed as CFO/COO at Surgical Intelligence Holding GmbH and as Global Finance Director at Stallergenes Greer. Extensive earlier experience includes roles at Waypoint Corporate Services Limited, where responsibilities encompassed group valuation, accounting policy, and senior financial control. Claire holds a CIMA qualification in Accounting from The Chartered Institute of Management Accountants and a Bachelor's degree in English Literature from the University of Birmingham.
This person is not in any teams
This person is not in any offices
CNX Therapeutics
2 followers
CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines. We commercialise and distribute a portfolio of speciality brands and hospital products in Europe, in 40 countries worldwide, both directly and through strategic partnerships. Our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.